PLP2 and triple-negative breast carcinoma: As for LINC00173, its high expression promoted the progression of cervical cancer by targeting miR-3171 [50], hepatocellular carcinoma via the microRNA-641/RAB14 axis [51], triple-negative breast cancer [52], glioma through sponging miR-765 [53], colorectal cancer by regulating the miR-765/PLP2 axis [54], and lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression [55].